Matinas biopharma holdings, inc. reports earnings results for the third quarter ended september 30, 2019

Matinas biopharma holdings, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 4.561 million compared to usd 2.954 million a year ago. net loss was usd 4.404 million compared to usd 2.935 million a year ago. basic loss per share from continuing operations was usd 0.03 compared to usd 0.03 a year ago. for the nine months, operating loss was usd 13.185 million compared to usd 10.479 million a year ago. net loss was usd 11.799 million compared to usd 10.456 million a year ago. basic loss per share from continuing operations was usd 0.09 compared to usd 0.12 a year ago.
MTNB Ratings Summary
MTNB Quant Ranking